• 検索結果がありません。

IR情報 決算短信 | 宝ホールディングス株式会社

N/A
N/A
Protected

Academic year: 2018

シェア "IR情報 決算短信 | 宝ホールディングス株式会社"

Copied!
21
0
0

読み込み中.... (全文を見る)

全文

(1)

宝ホ

連結

Takara Holdings Inc.

Consolidated

要約損益計算書

Consolidated Statements of Income by Business Group (Summary)

要約

借対照表

Consolidated Balance Sheets (Summary)

宝酒造

Takara Shuzo Group

要約損益計算書

Statements of Income (Summary)

要約

借対照表

Balance Sheets (Summary)

Takara Bio Group

要約損益計算書

Statements of Income (Summary)

要約

借対照表

Balance Sheets (Summary)

期 参考資料

Reference Data for the Year Ended March 31, 2017

Six-Year Financial Summary by Business Group

日 発表

業績予想数値

比較

Change from forecast anounced Jan. 30, 2017

期 業績予想

Financial forecast for the year ending March 31, 2018

宝ホ

連結

Takara Holdings Inc.

Consolidated

宝酒造

Takara Shuzo Co.,Ltd.

宝酒造 ン

Takara Shuzo International Group

Takara Bio Group

期 参考資料

Reference Data for the year ending March 31, 2018

FAX 075(241)5194

E-Mail [email protected]

決算短信補足資料

IR部

Investor Relations Dept.

TEL 075(241)5124

(2)

将来見通

関す 注意事項

資料中 当社

び当社

計画 見通

戦略 確信

歴史的事実

いも

将来 業績 関す 見通

現時

い 入手可能 情報

当社経営

断 基

くも

重大

確実性 含

い 情報

多く 仮定

び考え 基

す 実際 業績

要素

予測

大 く異

結果

実際 業績 影響

え 要素

経済情勢 特 消費動向

変動 法

行政制度 変

競合会社 価格 製品戦略

力 当社 既存製品

び新製品 販売力

生産中断 当社 知

的所

権 対す 侵害 急速

術革新 重大

決等 あ

業績 影響

要素

限定

宝ホールデ ン ス株式会社 IR部

Takara Holdings Inc. Investor Relations Dept.

T

7

X 7

9

a r ta ara c

Forward-Looking Statements

Statements in this document, other than those based on historical fact, concerning the current plans, prospects, strategies and

expectations of the Company and its Group represent forecasts of future results. While such statements are based on the

conclusions of management according to information available at the time of writing, they reflect many assumptions and opinions

derived from information that includes major risks and uncertainties. Actual results may vary significantly from these forecasts due to

various factors.

(3)

宝ホ

連結

:Takara Holdings Inc. ‐Consolidated‐

要約損益計算書

:Consolidated Statements of Income by Business Group (Summary)

百万 :Millions of Yen

FY2016

実績

予想

実績

増減 比 増減 比

Actual Forecast announced Actual Change % Difference % (a) Nov. 10, 2016 (b) (c) (c-a) (c/a) (c-b) (c/b)

宝酒造

そ 他

原価

総利益

費 保管料

広告宣伝費

研究開発費

管理費 そ 他

販売費及び一般管理費

宝酒造

そ 他

営業利益 △:損失

営業外収益

営業外費用

経常利益 △:損失

利益

損失

法人税

民税及び事業税

法人税等調整額

設備投資額

形 無形

減価償却費

形 無形

償却額

営業利益 経常利益 親会社株主 帰属す 当期純利益 成 期通期業績予想 修正 す p 参照 The Company revised FY2017 forecasts concerning Operating income, Ordinary income and Net income attributable to owners of the parent on January 30, 2017. (c.f. p13.)

営業外収益 利息 郤当金 持分法 投資利益 補助金収入

Non-operating income Interest income 193, Dividends income 465, Equity in earnings of affiliates 268, Subsidy income 288, etc. 営業外費用 支払利息 社債利息

Non-operating expenses Interest expense 224, Interest on bonds 257, etc. 特 利益 段階 得 差益 固定資産売却益

Extraordinary income Gain on step acquisitions 878, Gain on sales of noncurrent assets 206 etc. 特 損失 減損損失 固定資産 売却損

Extraordinary loss Impairment loss 667, Loss on sales and retirement of noncurrent assets 264, etc.

447 550

481

34 107.7% ᇞ 68 87.6%

Interest and discounts expenses

そ 他営業外費用

223 150

262

39 117.6% 112 175.3%

Other, net

747 650

659

ᇞ 87 88.2% 9 101.5%

Interest and Dividends income

1,082 750

878

ᇞ 204 81.1% 128 117.1%

Other, net

利息 郤当金

そ 他営業外収益

Takara Shuzo Group

Cost of sales Gross profit Other, net Takara Bio Group

Net sales

Sales promotion and allowance for s.p.

販売

進費 販売

進引当金繰入

Operating income(∆:loss) Research and development Transportation and storage

Other, net Advertising

SG&A expenses Takara Shuzo Group Takara Bio Group

Other, net

Takara Healthcare Inc.

税金等調整前当期純利益 △:損失

Net income attributable to the noncontrolling interest(∆:loss) Income before income taxes(∆:loss) Non-operating income

Non-operating expenses Ordinary income(∆:loss)

支払利息

当期純利益 △:損失

Net income(∆:loss) Extraordinary income Extraordinary loss

Current income taxes Deferred income taxes

755

41 105.9%

336 103.8%

Net income attributable to owners of the parent(∆:loss)

713

74

135 -

ᇞ 60

親会社株主 帰属す 当期純利益 △:損失

5,208

369 107.6% 12,548

700

7,769 8,900

9,236

1,466 118.9% 4,800

4,839

353 176 118.6%

106.0% 13,700

400 172.9% 550

14,520

1,971 115.7%

644

950

306 147.5%

820 671

950

14,344

1,504 111.7%

951 107.6% 12,600

744

73 111.0%

13,551

1,870 116.0%

44

137 109.8% 1,400

1,044 107.9% 13,300

1,126

773 318.9% 538 2,667 41 107.7% 555 7,055 8,410 35,000 4,700 29,700 77,815 2,850 1,830 11,680 12,840 280

4,550

29,673

100 480

1,537

ᇞ 292 84.0%

580

ᇞ 1,241 98.5%

81,700 103.4%

8,480

1,425 120.2%

120.9% 106.0% 9,200

3,202

535 120.1% 352 112.4%

9,755

1,345 116.0%

106.4% 700

55 108.0% 483 110.1%

80,458

2,643

ᇞ 166

821

ᇞ 58

1,986 102.5% 98.7% 107.2% 60 100.7% 8,682 95.0% 96.9% 98.0% 99.9% 96.8%

ᇞ 101

ᇞ 707

ᇞ 149

ᇞ 26 234,100 139,800

234,193

3,365 33,471 4,608 27,686 3,300

3,198

34,292

192,025 29,729 1,744

1,879

9,146

ᇞ 353

135

201,171

29,375

2,000

1,865 1,900

1,766

ᇞ 99

100.0% 94.0%

382

ᇞ 120

93

97.2% 99.7%

ᇞ 289 107.8%

64 70

12

ᇞ 51 19.7% ᇞ 57 18.2%

Takara Healthcare Inc.

225,364

94,300

140,182

94,010

4,514 105.0%

135,868 4,314 103.2%

103.9% 8,829

89,495

8,743

9,000 ᇞ 256

100.3%

Amortization of goodwill

非支郤株主 帰属す 当期純利益 △:損失

Capital expenditures 6,003

6,658

654 110.9%

ᇞ 28 99.5% 5,200

Depreciation and Amortization 5,179

5,171

ᇞ 8 99.8%

103.4% 8,200

20 100.3% 6,638

対前期 対 予想

Change from FY2016 Change from forecast anounced Nov. 2016 FY2017 / Apr. 1, 2016 - Mar. 31, 2017

538 460

586

47 108.8% 126 127.5%

94.7% 133 93.0% 104.8%

98.8%

99.8% 201,600

28,600

ᇞ 428

775 102.7%

(4)

要約

借対照表

:Consolidated Balance Sheets (Summary)

資産の部

:Assets

百万

:Millions of Yen

As of Mar. 31, 2016 As of Mar. 31, 2017 Change Reference

流動資産

(Total current assets)

億 :One hundred millions of Yen

現金及び預金

H+ + +

Cash and deposits

手形及び売掛金

Notes and accounts receivable-trade

価証券

H△ △

Marketable securities

卸資産

Inventories

そ 他

Other current assets

倒引当金

Allowance for doubtful accounts

固定資産

(Total fixed assets)

形固定資産

[Property, plant and equipment]

建物及び構築物

当期 形 無形固定資産 増減

Buildings and structures Reference of Property, plant and equipment and Intangible assets

機械装置及び運搬具

新規 得 + + +

Machinery, equipment and vehicles Newly purchases +66.5

土地

減価償却 △ △ △

Land Depreciation ∆51.7

そ 他

そ 他増減 +

Other property, plant and equipment Other, net +38.6

無形固定資産

[Intangible fixed assets]

Goodwill

そ 他

Other intangible fixed assets

投資そ 他 資産

[Investments and other assets]

投資

価証券

H+ △

Investment securities

そ 他

Other assets

倒引当金

Allowance for doubtful accounts

資産合計

Total assets

(TH=Takara Holdings Inc., TS=Takara Shuzo Group, TB=Takara Bio Group)

増減

主 増減理由

173,912

159,073

14,839

58,073

38,386

19,686

57,951

53,602

4,349

13,237

28,238

15,000

39,851

34,218

5,632

5,035

4,859

175

236

231

5

100,456

94,179

6,276

59,174

53,065

6,108

20,952

17,735

3,216

12,315

12,554

239

20,089

18,118

1,970

5,816

4,656

1,160

10,256

11,010

754

31,025

30,103

922

6,975

6,626

349

4,035

3,630

405

25,583

24,747

835

274,368

253,253

21,115

5,533

5,468

64

90

(5)

要約

借対照表

:Consolidated Balance Sheets (Summary)

負債及び純資産

の部

:Liabilities and net assets

百万

:Millions of Yen

As of Mar. 31, 2016 As of Mar. 31, 2017 Change Reference

流動

(Total current liabilities)

億 :One hundred millions of Yen

支払手形及び

掛金

Notes and accounts payable-trade

短期借入金

Short-term loans payable

償還 社債

H+

Current portion of bonds 第9回普通社債 7年9月償還 第 回普通社債 7年 月償還

#9SB (Redemption, Sept. 2017) #12SB (Redemption, Apr. 2017)

払酒税

Accrued alcohol tax

払費用

Accrued expenses

販売

進引当金

そ 他

Other current liabilities

固定

(Total non-current liabilities)

社債

H△

Bonds payable 第9回普通社債 7年9月償還 第 回普通社債 7年 月償還

#9SB (Redemption, Sept. 2017) #12SB (Redemption, Apr. 2017)

長期借入金

Long-term loans payable

職給付

Net defined benefit liability

預 金

Deposits from customers

そ 他

Other non-current liabilities

債合計

Total liabilities

Capital stock

剰余金

Capital surplus

利益剰余金

Retained earnings

自己株式

Treasury stock

株主資

(Total owner's equity)

そ 他

価証券評価差額金

H+

繰延

ッ 損益

替換算調整

△ △

USD=116.53JPY, EUR=122.73JPY, GBP=143.06JPY (Dec. 2016) USD=120.54JPY, EUR=131.67JPY, GBP=178.60JPY (Dec. 2015)

職給付

調整累計額

そ 他 包括利益累計額

非支郤株主持分

(Noncontrolling interests)

純資産合計

Total net assets

債純資産合計

Total liabilities and net assets

(TH=Takara Holdings Inc., TS=Takara Shuzo Group, TB=Takara Bio Group)

264

Remeasurements of defined benefit plans

増減

主 増減理由

274,368

253,253

21,115

30,877

25,762

5,115

165,920

156,148

9,771

1,650

1,879

229

119,729

113,663

5,836

9,939

0

124,667

9,938

0

6,066

118,830

445

Reserve for sales promotion expenses

13,226

13,226

108,447

97,104

11,343

5,342

5,379

36

20,000

10,000

10,996

10,255

7,640

5,277

(Total valuation and translation adjustments)

445

9,583

6,822

2,760

11,555

1,179

Valuation difference on available-for-sale securities

Deffered gains or losses on hedges

Translation adjustments

5,548

1,426

4,122

10,375

370

634

2,362

741

8,544

8,961

416

5,562

4,965

597

1,899

1,870

29

10,000

7,593

7,855

261

4,994

4,212

10,000

10,000

9,206

14,439

12,760

1,678

42,941

49,456

6,514

65,506

47,648

17,858

16,804

15,201

1,603

(6)

宝酒造

:Takara Shuzo Group

要約損益計算書

:Statements of Income (Summary)

百万

:Millions of Yen

Y

実績

予想

実績

増減

増減

Actual Forecast Actual Change % Difference % (a) Nov. 10, 2016 (b) (c) (c-a) (c/a) (c-b) (c/b)

焼郥

清酒

飲料

そ 他酒類

そ 他調味料

原料用

海外日

食材卸

そ 他

原価

総利益

費 保管料

広告宣伝費

研究開発費

管理費 そ 他

販売費及び一般管理費

営業利益 △:損失

営業外収益

営業外費用

経常利益 △:損失

利益

損失

法人税

民税及び事業税

法人税等調整額

営業利益 経常利益 親会社株主 帰属す 当期純利益 成 期通期業績予想 修正 す p 参照

The Company revised FY2017 forecasts concerning Operating income, Ordinary income and Net income attributable to owners of the parent on January 30, 2017. (c.f. p13.)

設備投資額

形 無形

減価償却費

形 無形

償却額

99.8%

96.4%

102.9%

280

101.2%

104.5%

858

98.9%

97.5%

428

96.6%

662

9,146

15

71,138

192,025

Transportation and storage

8,300

2,700

87.9%

32,405

329

104.7%

33,337

344

104.8%

201,600

125,900

5,442

2,723

7,924

103.6%

7,500

Raw alcohol

7,197

7,771

573

108.0%

12,300

Other

13,641

11,987

1,653

312

20,668

26,800

28,933

8,265

140.0%

2,133

108.0%

Japanese food wholesale business in overseas markets

99.7%

3,200

110.7%

2,952

8

317

107.4%

101

931

1,417

97.9%

103.4%

6,700

1,413

97.9%

103.8%

1,453

126.5%

102.6%

55

100.9%

98.1%

86.1%

23

97.7%

100.3%

803

110.7%

97.8%

59,300

25,200

1,298

377

対前期

予想

FY2017 / Apr. 1, 2016 - Mar. 31, 2017 Change from FY2016

98.5%

Change from forecast anounced Nov. 2016

97.5%

1,374

85

2,981

100.8%

75,700

126,329

74,841

3,703

105.2%

429

99.6%

14,116

53

9,749

435

116

100.3%

98.6%

15,200

100.5%

104.7%

49

9,700

113

99.2%

208

271

125

601

79.4%

2,358

95

66,500

5,474

156

10

8,019

2,824

34,000

400

21,100

6,927

441

8,570

124

5,663

2,781

19,244

65,086

20,661

62,728

8,410

9,755

1,345

8,726

100

925

839

1077.7%

85

757

114.0%

546

105.8%

116.0%

410

555

31

92.9%

9,400

1

10

400

438

200

394

112.3%

3,200

2

122

1.8%

0

199

6,900

7,126

1,463

125.8%

226

103.3%

3,592

810

129.1%

106.0%

9,200

9,946

1,220

Other, net Advertising

Sales promotion and allowance for s.p.

販売

進費 販売

進引当金繰入

Operating income(∆:loss) Research and development

10,721

2,151

125.1%

115.7%

800

151

91

62.3%

242

51

151.1%

621

106.2%

10,100

100.2%

600

SG&A expenses

親会社株主 帰属す 当期純利益 △:損失

Extraordinary gain

Extraordinary loss

Current income taxes

Deferred income taxes

税金等調整前当期純利益 △:損失

Net income attributable to the noncontrolling interest(∆:loss) Income before income taxes(∆:loss) Non-operating income

Non-operating expenses

Ordinary income(∆:loss)

当期純利益 △:損失

Net income(∆:loss) Shochu

Cost of sales

Gross profit

Light-alcohol refreshers Sake

Net sales

Other liquors

14,000

14,991

14,170

59,376

24,736

27,815

31,600

30,796

201,171

120,886

58,001

24,822

Hon Mirin

9,314

Other seasonings

15,104

357

280

424

66

118.6%

144

151.4%

Amortization of goodwill

非支郤株主 帰属す 当期純利益 △:損失

Net income attributable to owners of the parent(∆:loss)

105.4%

189

227

Capital expenditures

2,919

3,269

349

112.0%

Depreciation and Amortization

3,252

3,191

60

98.1%

(7)

要約

借対照表

:Balance Sheets (Summary)

資産の部

:Assets

百万

:Millions of Yen

As of Mar. 31, 2016 As of Mar. 31, 2017 Change Reference

流動資産

(Total current assets)

億 :One hundred millions of Yen

現金及び預金

ミ ィ ク +

Cash and deposits Mutual Trading +32.1

手形及び売掛金

ミ ィ ク +

Notes and accounts receivable-trade Mutual Trading +33.9

価証券

Marketable securities

卸資産

ミ ィ ク +

Inventories Mutual Trading +49.1

そ 他

Other current assets

倒引当金

Allowance for doubtful accounts

固定資産

(Total fixed assets)

形固定資産

[Property, plant and equipment]

建物及び構築物

当期 形 無形固定資産 増減

Buildings and structures Reference of Property, plant and equipment and Intangible assets

機械装置及び運搬具

新規 得 +

Machinery, equipment and vehicles Newly purchases +32.6

土地

減価償却 △

Land Depreciation ∆31.9

そ 他

そ 他増減 +

Other property, plant and equipment Other, net +52.7

無形固定資産

[Intangible fixed assets]

Goodwill

そ 他

Other intangible fixed assets

投資そ 他 資産

[Investments and other assets]

投資

価証券

ミ ィ ク 社 連結子会社 投資 消去 △

Investment securities Elimination of investment securities resulting from the conversion of Mutual Trading into a new consolidated subsidiary △3,052

そ 他

Other assets

倒引当金

Allowance for doubtful accounts

資産合計

Total assets

3,541

6,393

2,852

166,697

150,773

15,924

3,842

3,872

29

43

58

14

7,541

7,992

451

7,340

10,208

2,867

5,334

5,412

78

2,658

2,129

529

9,229

6,991

2,238

2,923

2,023

900

11,781

8,964

2,817

9,894

10,010

116

48,711

46,191

2,519

33,829

27,990

5,838

4,870

4,769

101

204

188

15

10,237

10,516

278

34,184

28,962

5,221

18,873

14,321

4,551

50,025

46,201

3,824

増減

主 増減理由

117,986

104,582

13,404

(8)

要約

借対照表

:Balance Sheets (Summary)

負債及び純資産

の部

:Liabilities and net assets

百万

:Millions of Yen

As of Mar. 31, 2016 As of Mar. 31, 2017 Change Reference

流動

(Total current liabilities)

億 :One hundred millions of Yen

支払手形及び

掛金

ミ ィ ク +

Notes and accounts payable-trade Mutual Trading +11.5

短期借入金

ミ ィ ク + 宝酒造 +

Short-term loans payable Mutual Trading +43.9, Takara Shuzo +10.0

払酒税

Accrued alcohol tax

払費用

ミ ィ ク +

Accrued expenses Mutual Trading +7.4

販売

進引当金

そ 他

Other current liabilities

固定

(Total non-current liabilities)

長期借入金

Long-term loans payable

職給付

Net defined benefit liability

預 金

Deposits from customers

そ 他

Other non-current liabilities

債合計

Total liabilities

Capital stock

剰余金

宝酒造△

Capital surplus Takara Shuzo △25.2

利益剰余金

Retained earnings

株主資

(Total owner's equity)

そ 他

価証券評価差額金

繰延

ッ 損益

替換算調整

xc an e ate

USD=116.53JPY, EUR=122.73JPY, GBP=143.06JPY (Dec. 2016) USD=120.54JPY, EUR=131.67JPY, GBP=178.60JPY (Dec. 2015)

職給付

調整累計額

そ 他 包括利益累計額

非支郤株主持分

ミ ィ ク +

(Noncontrolling interests) Mutual Trading +41.3

純資産合計

Total net assets

債純資産合計

Total liabilities and net assets

3,460

Translation adjustments

7,601

7,870

268

5,169

2,752

36,279

29,351

6,927

50,109

52,861

4,907

261

4,040

867

1,899

1,870

29

144

3,026

87,388

83,213

4,175

0

445

445

132

567

435

3,654

193

7,380

2,239

5,141

166,697

150,773

15,924

95,170

88,880

6,289

48,687

40,948

7,739

13,719

12,300

1,419

10,918

5,642

5,276

7,593

7,855

9,648

9,238

409

22,840

20,944

1,895

6,793

6,319

474

Remeasurements of defined benefit plans

(Total valuation and translation adjustments)

3,427

400

361

217

増減

主 増減理由

Reserve for sales promotion expenses

Valuation difference on available-for-sale securities

Deffered gains or losses on hedges

71,527

61,893

9,634

1,000

1,000

5,219

50

3,006

(9)

:Takara Bio Group

要約損益計算書

:Statements of Income (Summary)

百万

:Millions of Yen

Y

実績

予想

実績

増減

増減

Actual Forecast Actual Change % Difference % (a) Nov. 19, 2016 (b) (c) (c-a) (c/a) (c-b) (c/b)

研究用試薬

学機器

そ 他

産業支援 計

遺伝子医療

医食品バ

原価

総利益

費 保管料

広告宣伝費

研究開発費

管理費 そ 他

販売費及び一般管理費

遺伝子医療

医食品バ

共通

営業利益 △:損失

営業外収益

営業外費用

経常利益 △:損失

利益

損失

法人税

民税及び事業税

法人税等調整額

売 高 営業利益 経常利益 成 期通期業績予想 修正 す p 参照

The Company revised FY2017 forecasts concerning Net sales, Operating income and Ordinary income on January 30, 2017. (c.f. p13.)

設備投資額

形 無形

減価償却費

形 無形

償却額

747

2,301

104

6

94.1%

110

1

669

13,688

13,655

61

1,773

6,218

6,138

13,749

93

100.7%

1,380

393

79

101.3%

69

Research reagents

Cost of sales

Gross profit

Contracted service and other Scientific instruments

Net sales

Transportation and storage

Other, net Advertising

Sales promotion

販売

進費

Research and development Bioindustry

Gene Therapy

AgriBio

Net income attributable to owners of the parent(∆:loss) SG&A expenses

親会社株主 帰属す 当期純利益 △:損失

Extraordinary income

Extraordinary loss

Current income taxes

Deferred income taxes

税金等調整前当期純利益 △:損失

Net income attributable to the noncontrolling interest(∆:loss) Income before income taxes(∆:loss) Non-operating income

Non-operating expenses

Ordinary income(∆:loss) Operating income(∆:loss) Bioindustry

Gene Therapy

Eliminations/Corporate

産業支援

当期純利益 △:損失

Net income(∆:loss) AgriBio

101.4%

642

69

4

352

112.4%

3,301

429

102.2%

2

2,667

8

6

1

62.5%

113.6%

3,150

60

852.4%

2

91.3%

3,579

277

1,808

106

112.8%

10

103.0%

102.7%

89

854

33

117

13

47

101.9%

102.5%

594

500

500

87.1%

72.6%

87.9%

94.7%

500

378

13,405

12,061

983

92.7%

399

380

395

203.9%

108.4%

2,049

55

65.1%

160

0

2,850

3,202

535

118.6%

375

120.1%

1,737

1,739

2,200

Capital expenditures

1,648

441

100.2%

1,350

445

196

69.4%

68

2,905

33

101.2%

5

2,771

88

83.1%

3

31

102.2%

1,417

43

75

775

376

194.2%

1,334

2

1,492

160

90.3%

1,653

44

1,340

96.6%

1,353

59.4%

0

3

2

2,805

99

28,600

629

103.9%

174

286

103.7%

95.9%

8,110

29,375

360

対前期

予想

FY2017 / Apr. 1, 2016 - Mar. 31, 2017 Change from FY2016 Change from forecast anounced Nov. 2016

775

2,404

26,195

99.6%

19,515

2,663

78

247

19,436

2,911

98.8%

109.3%

95.6%

102

95.7%

353

105.2%

209

100.5%

2,408

1,356

16

101.2%

2

100.2%

901

4,275

7,824

971

4,275

7,654

4,101

174

456

37

94.1%

414

258

96.0%

6,476

16,538

12,422

122

95.9%

106.0%

27,320

632

16,323

584

102

94.9%

16,952

29,729

20,488

3,087

3,744

97.3%

4,015

4,225

94.3%

1,051

176

480

26,573

181

159

162

18

89.6%

3

102.0%

Amortization of goodwill

非支郤株主 帰属す 当期純利益 △:損失

1,352

18

101.4%

31

2,090

98.2%

1,753

74.9%

78.9%

Depreciation and Amortization

1,687

1,722

34

102.0%

551

(10)

要約

借対照表

:Balance Sheets (Summary)

資産の部

:Assets

百万

:Millions of Yen

As of Mar. 31, 2016 As of Mar. 31, 2017 Change Reference

流動資産

(Total current assets)

億 :One hundred millions of Yen

現金及び預金

ホ ィ ク バ △

Cash and deposits Takara Bio USA Holdings +139.2, Takara Bio △57.4

手形及び売掛金

Notes and accounts receivable-trade

価証券

バ △

Marketable securities Takara Bio △69.9

卸資産

Inventories

そ 他

Other current assets

倒引当金

Allowance for doubtful accounts

固定資産

(Total fixed assets)

形固定資産

[Property, plant and equipment]

建物及び構築物

当期 形 無形固定資産 増減

Buildings and structures Reference of Property, plant and equipment and Intangible assets

機械装置及び運搬具

新規 得 +

Machinery, equipment and vehicles Newly purchases +16.4

土地

減価償却 △

Land Depreciation ∆17.2

そ 他

そ 他増減 △

Other property, plant and equipment Other, net △12.7

無形固定資産

[Intangible fixed assets]

Goodwill

そ 他

Other intangible fixed assets

投資そ 他 資産

[Investments and other assets]

長期前払費用

Long-term prepaid expenses

そ 他

Other assets

倒引当金

Allowance for doubtful accounts

資産合計

Total assets

43,964

42,158

1,806

28,078

19,384

8,693

7,455

6,830

625

2,000

9,721

7,721

5,462

5,100

362

998

1,163

164

30

41

11

23,178

24,432

1,254

19,577

20,534

957

7,667

8,207

540

2,349

2,461

111

7,297

7,696

398

165

2,263

2,170

93

2,301

2,695

394

1,641

1,213

427

1,054

1,087

33

増減

主 増減理由

67,143

66,591

552

454

192

262

11

11

1,299

1,202

97

(11)

要約

借対照表

:Balance Sheets (Summary)

負債及び純資産

の部

:Liabilities and net assets

百万

:Millions of Yen

As of Mar. 31, 2016 As of Mar. 31, 2017 Change Reference

流動

(Total current liabilities)

億 :One hundred millions of Yen

支払手形及び

掛金

Notes and accounts payable-trade

短期借入金

Short-term loans payable

そ 他

Other current liabilities

固定

(Total non-current liabilities)

長期借入金

Long-term loans payable

職給付

Net defined benefit liability

そ 他

Other non-current liabilities

債合計

Total liabilities

Capital stock

剰余金

Capital surplus

利益剰余金

Retained earnings

株主資

(Total owner's equity)

替換算調整

xc an e ate

USD=116.53JPY, EUR=122.73JPY, GBP=143.06JPY (Dec. 2016) USD=120.54JPY, EUR=131.67JPY, GBP=178.60JPY (Dec. 2015)

職給付

調整累計額

そ 他 包括利益累計額

非支郤株主持分

(Noncontrolling interests)

純資産合計

Total net assets

債純資産合計

Total liabilities and net assets

488

622

134

32,893

1,136

677

5

431

4,033

3,675

358

1,131

1,050

81

Translation adjustments

32,893

10,432

9,295

7,157

6,480

14,965

14,965

426

(Total valuation and translation adjustments)

2,852

1,593

2,023

3,109

1,086

1,258

257

429

172

Remeasurements of defined benefit plans

253

47

63

16

67,143

66,591

552

59,985

60,110

124

130

82

47

増減

主 増減理由

100

102

2

58,291

57,155

1,136

6,025

5,430

595

1,944

1,690

(12)

期 参考資料

:Reference Data for the Year Ended March 31, 2017

替前提及び売

高 対す

変動 影響

:Exchange rates and effect of change in exchange rates on net sales

替前提 海外子会社P

換算用

:Exchange rates for the income statement of oversea subsidiaries : Yen

Y

実績

予想

実績

Actual Forecast announced Actual

前期差

予想差

(a) Nov. 10, 2016 (b) (c) Change(c-a) Difference(c-b)

121.11

106.40

108.81

12.30

2.41

185.20

146.10

147.64

37.56

1.54

134.31

118.60

120.30

14.01

1.70

19.23

16.10

16.36

2.87

0.26

10.71

9.10

9.37

1.34

0.27

1.89

1.59

1.62

0.27

0.03

14.36

12.60

12.72

1.64

0.12

88.25

77.70

78.76

9.49

1.06

◆売

高 対す

変動 影響額

:Effect of change in exchange rates on net sales

百万

:Millions of Yen

対前期

予想

Change from FY2016 Change from forecast anounced Nov. 2016

焼郥

Shochu

清酒

Sake

飲料

Light-alcohol refreshers

そ 他酒類

Other liquors Hon Mirin

そ 他調味料

Other seasonings

原料用

Raw alcohol

海外日

食材卸

Japanese food wholesale business in overseas markets

そ 他

Other

宝酒造

Net sales of Takara Shuzo Group

研究用試薬

Research reagents

学機器

Scientific instruments

そ 他

Contracted service and other

産業支援 計

Bioindustry

遺伝子医療

Gene Therapy

医食品バ

AgriBio

Net sales of Takara Bio Group

宝ホ

海外売

高比率 推移

:Change in overseas sales ratio

宝酒造

Takara Shuzo Group

Takara Bio Group

そ 他

3

FY2017 / Apr. 1, 2016 - Mar. 31, 2017

US dollar

Pound Euro

人民元

Yuan

ウ ン

100 Won

Rupee

Singapore dollar

23

Sweden krona

284

48

4

0

827

81

58

8

46

7

3,132

951

4,377

1,100

1,854

263

17

2

138

16

2,010

282

FY2017

50.4%

FY2013 FY2014

18.5%

15.7%

13.7%

8.9%

5.8%

54.2%

50.3%

45.9%

39.1%

FY2015 FY2016

2,010

282

(13)

-Consolidated-海外主要子会社 業績

:Financial Result of major overseas subsidiaries

営業利益

営業利益

Net Sales Operating income(∆:loss) Net Sales Operating income(∆:loss)

千 :Thousands of US dollar 31,052 3,676 32,782 4,750

百 万 :Millions of Yen 3,760 445 3,567 516

千 元 :Thousands of Yuan 48,326 3,262 46,997 2,404

百 万 :Millions of Yen 929 62 768 39

千 ン :Thousands of Pound 15,576 3,091 14,509 3,364

百 万 :Millions of Yen 2,884 572 2,142 496

千 :Thousands of US dollar 17,173 6,256 20,479 7,774

百 万 :Millions of Yen 2,079 757 2,228 845

千 :Thousands of Euro 113,473 12,009 133,913 15,764

百 万 :Millions of Yen 15,240 1,612 16,109 1,896

千 ン :Thousands of Pound 29,513 2,868 34,481 1,995

百 万 :Millions of Yen 5,465 531 5,090 294

千 :Thousands of Euro 17,314 2,121 19,372 2,299

百 万 :Millions of Yen 2,325 284 2,330 276

千 :Thousands of Sweden Krona 27,314 ᇞ 16,576 28,009 ᇞ 15,329

百 万 :Millions of Yen 392 ᇞ 238 356 ᇞ 194

千 元 :Thousands of Yuan 291,253 125,143 305,664 124,340

百 万 :Millions of Yen 5,600 2,406 5,000 2,034

千 元 :Thousands of Yuan 96,756 ᇞ 1,650 135,179 3,737

百 万 :Millions of Yen 1,860 ᇞ 31 2,211 61

百 万 :Millions of Won 8,601 999 8,921 1,250

百 万 :Millions of Yen 921 107 835 117

千 :Thousands of Rupee 187,515 766 196,570 ᇞ 581

百 万 :Millions of Yen 354 1 318 ᇞ 0

千 :Thousands of US dollar 67,962 11,996 75,697 16,996

百 万 :Millions of Yen 8,230 1,452 8,236 1,849

宝酒造

営業利益増減要因

:Factors of change in operating income of Takara Shuzo Group 百万 :Millions of Yen

対前期増減

対 予想増減

Change from FY2016 Change from forecast anounced Nov. 2016

+1,345

+555

※利益 増加要因 減少要因 △ 表示 *An increasing factor and a decreasing factor on profit are shown + and △, respectively

期 実績

期 実績

FY2016 Actual FY2017 Actual

FOODEX Group

TAZAKI FOODS LTD.

米国宝酒造

Takara Sake USA Inc.

宝酒造食品

Takara Shuzo Foods Co.,Ltd.

The Tomatin Distillery Co.,Ltd. AGE INTERNATIONAL,INC.

Takara Bio Europe S.A.S. Takara Bio Europe AB

数量差 単価差

DSS Takara Bio India Private Limited

要因

Change in quantities +1,665 Change in unit price +574 Change in quantities △166 Change in unit price △1,364

宝生物工程 大連

Takara Biotechnology (Dalian) Co.,Ltd.

宝日医生物

Takara Biomedical Technology Beijing) Co., Ltd.

メ ィ

Takara Korea Biomedical Inc.

数量差 単価差 数量差 △ 単価差 △

Takara Bio USA, Inc.

TAKARA SHUZO CO.,LTD.

➣主 Breakdown

Factors Detail Detail

販売費及び一般管理費 増減

宝酒造単体

Change in SG&A expenses of TAKARA

SHUZO CO.,LTD. 販売 進費 減少

Change in Sales promotion and allowance for s.p. △984 Shochu △179 (Change in quantities △581 Change in unit price +402)

Sake +177 (Change in quantities +327 Change in unit price △149)

総利益 増減

宝酒造単体

Change in Gross profit of TAKARA SHUZO CO.,LTD.

1,236

1,530

+2,240

広告宣伝費 減少 Change in Advertising +72 焼郥△ 数量差△ 単価差 清酒 数量差 単価差△

Change in Advertising +40

+1,398

*Included in changes above ※ 数量差 び単価差 含

132

+1,003

Change in Sales promotion and allowance for s.p. +558 販売 進費 増加 △

宝酒造

Takara Shuzo Group

海外日 食材卸会社 ※ 償却

+688

運 費 増加 △ 運 費 減少

Light-alcohol refreshers +1,566( Change in quantities +1,394 Change in unit price +172)

Hon Mirin+113 (Change in quantities +2 Change in unit price +111) 数量差 単価差

Change in Transportation △302

宝酒造単体 計

参考 原価コ ウン ※ 数量差 び単価差 含 Reference :Cost reduction +417

参考 原価コ ウン △ Reference :Cost reduction △202

*Included in changes above

Change in Transportation +79 広告宣伝費 減少

Japanese food wholesale business in overseas markets +149

TAZAKI FOODS LTD. △0

Mutual Trading +26 *Include amortization of goodwill そ 他 海外子会社

そ 他 子会社

営業利益 増減

Change in Operating income of other subsidiaries

+341

Elimination of intra-company transactions,etc. △168 連結消去等 △

Domestic subsidiaries +76 国 子会社

Other overseas subsidiaries +63 そ 他 海外子会社

Mutual Trading +263 *Include amortization of goodwill

Foodex Group +303

Japanese food wholesale business in overseas markets +369

Other overseas subsidiaries +322 国 子会社

Domestic subsidiaries +79 連結消去等

Elimination of intra-company transactions,etc. +136

ャ ン ャ ン

Foodex Group +123

ッ キ △ ッ キ △

TAZAKI FOODS LTD. △196

海外日 食材卸会社 ※ 償却

(14)

:Six-Year Financial Summary by Business Group

宝ホールデ ン ス 連結 :Takara Holdings Inc. -Consolidated- 百万 :Millions of Yen

成 成 成 成 成 成

期 期 期 期 期 期

増減 比

Change YOY% 198,690 200,989 209,568 219,490 225,364 234,193 8,829 103.9%

売 原価 Cost of sales 121,462 123,630 129,447 134,390 135,868 140,182 4,314 103.2%

売 高原価率 (Ratio to Net sales) 61.1% 61.5% 61.8% 61.2% 60.3% 59.9% -0.4pt -

77,228 77,359 80,121 85,099 89,495 94,010 4,514 105.0%

販売費及び一般管理費 SG&A expenses 67,963 68,225 70,631 74,003 77,815 80,458 2,643 103.4%

売 高販管費率 (Ratio to Net sales) 34.2% 33.9% 33.7% 33.7% 34.5% 34.4% -0.2pt -

9,264 9,133 9,490 11,096 11,680 13,551 1,870 116.0%

売 高営業利益率 (Ratio to Net Sales) 4.7% 4.5% 4.5% 5.1% 5.2% 5.8% +0.6pt -

32,436 32,838 32,954 32,818 33,471 34,292 821 102.5%

売 高販 費率 (Ratio to Net sales) 16.3% 16.3% 15.7% 15.0% 14.9% 14.6% -0.2pt -

3,027 3,090 3,376 3,754 4,608 4,550 ᇞ 58 98.7%

売 高研究開発費率 (Ratio to Net sales) 1.5% 1.5% 1.6% 1.7% 2.0% 1.9% -0.1pt -

5,330 5,282 8,967 9,533 6,003 6,658 654 110.9%

4,431 4,251 4,287 4,662 5,179 5,171 ᇞ 8 99.8%

271 267 348 500 538 586 47 108.8%

宝酒造 ルー :Takara Shuzo Group 百万 :Millions of Yen

成 成 成 成 成 成

期 期 期 期 期 期

増減 比

Change YOY% 175,503 176,946 182,306 190,089 192,025 201,171 9,146 104.8%

売 原価 Cost of sales 110,454 112,384 116,619 120,691 120,886 126,329 5,442 104.5%

売 高原価率 (Ratio to Net sales) 62.9% 63.5% 64.0% 63.5% 63.0% 62.8% -0.2pt -

65,049 64,562 65,686 69,397 71,138 74,841 3,703 105.2%

販売費及び一般管理費 SG&A expenses 58,280 58,174 59,357 61,556 62,728 65,086 2,358 103.8%

売 高販管費率 (Ratio to Net sales) 33.2% 32.9% 32.6% 32.4% 32.7% 32.4% -0.3pt -

6,768 6,387 6,329 7,840 8,410 9,755 1,345 116.0%

売 高営業利益率 (Ratio to Net sales) 3.9% 3.6% 3.5% 4.1% 4.4% 4.8% +0.5pt -

31,433 31,815 31,889 31,818 32,405 33,337 931 102.9%

売 高販 費率 (Ratio to Net sales) 17.9% 18.0% 17.5% 16.7% 16.9% 16.6% -0.3pt -

2,743 2,529 2,954 4,594 2,919 3,269 349 112.0%

3,225 2,997 2,968 3,170 3,252 3,191 ᇞ 60 98.1%

146 148 217 363 357 424 66 118.6%

タ ラバ ルー :Takara Bio Group 百万 :Millions of Yen

成 成 成 成 成 成

期 期 期 期 期 期

増減 比

Change YOY% 19,578 20,564 23,905 25,969 29,729 29,375 ᇞ 353 98.8%

売 原価 Cost of sales 9,194 9,540 11,331 12,142 13,405 12,422 ᇞ 983 92.7%

売 高原価率 (Ratio to Net sales) 47.0% 46.4% 47.4% 46.8% 45.1% 42.3% -2.8pt -

10,383 11,024 12,574 13,827 16,323 16,952 629 103.9%

販売費及び一般管理費 SG&A expenses 8,836 9,332 10,619 11,524 13,655 13,749 93 100.7%

売 高販管費率 (Ratio to Net sales) 45.1% 45.4% 44.4% 44.4% 45.9% 46.8% +0.9pt -

1,547 1,691 1,954 2,302 2,667 3,202 535 120.1%

売 高営業利益率 (Ratio to Net sales) 7.9% 8.2% 8.2% 8.9% 9.0% 10.9% +1.9pt -

2,658 2,715 3,026 3,401 4,275 4,101 ᇞ 174 95.9%

売 高研究開発費率 (Ratio to Net sales) 13.6% 13.2% 12.7% 13.1% 14.4% 14.0% -0.4pt -

926 2,397 5,538 4,762 2,090 1,648 ᇞ 441 78.9%

1,077 1,104 1,157 1,347 1,687 1,722 34 102.0%

124 119 131 136 181 162 ᇞ 18 89.6%

宝 ルス :Takara Healthcare Inc. 百万 :Millions of Yen

成 成 成 成 成 成

期 期 期 期 期 期

増減 比

Change YOY% 2,338 2,008 1,424 1,652 1,865 1,766 ᇞ 99 94.7%

売 原価 Cost of sales 1,492 1,233 674 803 893 669 ᇞ 223 74.9%

売 高原価率 (Ratio to Net sales) 63.8% 61.4% 47.4% 48.6% 47.9% 37.9% -10.0pt -

845 774 749 848 972 1,097 124 112.8%

販売費及び一般管理費 SG&A expenses 960 797 728 810 907 1,084 176 119.5%

売 高販管費率 (Ratio to Net sales) 41.1% 39.7% 51.1% 49.1% 48.6% 61.4% +12.7pt - ᇞ 114 ᇞ 22 21 38 64 12 ᇞ 51 19.7%

売 高営業利益率 (Ratio to Net sales) - - 1.5% 2.3% 3.5% 0.7% -2.7pt -

1,220 1,265 1,424 1,652 1,865 1,766 ᇞ 99 94.7%

前期対比

Change from FY2016

FY2017

売 高 Net sales

FY2012 FY2013 FY2014 FY2015 FY2016

売 総利益 Gross profit

営業利益 △:損失 Operating income(∆:loss)

販売 進費 販売 進引当金繰入Sales promotion and allowance for s.p.

研究開発費 R&D expenses

設備投資額 形 無形 Capital expenditures

減価償却費 形 無形 Depreciation and Amortization

前期対比

Change from FY2016

FY2012 FY2013 FY2014 FY2015 FY2016 FY2017

売 高 Net sales

売 総利益 Gross profit

営業利益 △:損失 Operating income(∆:loss)

販売 進費 販売 進引当金繰入Sales promotion and allowance for s.p.

設備投資額 形 無形 Capital expenditures

減価償却費 形 無形 Depreciation and Amortization

営業利益 △:損失 Operating income(∆:loss)

前期対比

Change from FY2016

FY2012 FY2013 FY2014 FY2015 FY2016 FY2017

前期対比

Change from FY2016

FY2012 FY2013 FY2014 FY2015 FY2016 FY2017

設備投資額 形 無形

売 高 Net sales

売 総利益 Gross profit

営業利益 △:損失 Operating income(∆:loss)

事業売 高 Net sales of Healthcare products

償却額 Amortization of goodwill

償却額 Amortization of goodwill

償却額 Amortization of goodwill

研究開発費 R&D expenses

設備投資額 形 無形 Capital expenditures

減価償却費 形 無形 Depreciation and Amortization

売 高 Net sales

(15)

日 発表

業績予想数値

比較

:Change from forecast anounced Jan. 30, 2017

宝ホ

連結

:

Takara Holdings Inc.

-Consolidated-百万 :Millions of Yen

FY2016

実績

予想

実績

増減 比 増減 比

Actual Forecast announced Actual Change % Difference % (a) Jan. 30, 2017 (b) (c) (c-a) (c/a) (c-b) (c/b)

営業利益 △:損失

経常利益 △:損失

宝酒造

Takara Shuzo Group

百万 :Millions of Yen

FY2016

実績

予想

実績

増減 比 増減 比

Actual Forecast announced Actual Change % Difference % (a) Jan. 30, 2017 (b) (c) (c-a) (c/a) (c-b) (c/b)

営業利益 △:損失

経常利益 △:損失

Takara Bio Group

百万 :Millions of Yen

FY2016

実績

予想

実績

増減 比 増減 比

Actual Forecast announced Actual Change % Difference % (a) Jan. 30, 2017 (b) (c) (c-a) (c/a) (c-b) (c/b)

営業利益 △:損失

経常利益 △:損失

対前期 対 予想

FY2017 / Apr. 1, 2016 - Mar. 31, 2017 Change from FY2016 Change from forecast anounced Jan. 2017

100.0%

Net sales

11,680 13,100

13,551

1,870 116.0% 451 103.4%

Operating income(∆:loss)

225,364 234,100

234,193

8,829 103.9% 93

103.9%

Ordinary income(∆:loss)

7,055 8,300

8,480

1,425 120.2% 180 102.2% Net income attributable to owners of the parent(∆:loss)

12,840 13,800

14,344

1,504 111.7% 544

101.9%

Operating income(∆:loss)

8,726 9,600

9,946

1,220 114.0%

99.8%

Net sales

8,410 9,400

9,755

1,345 116.0% 355 103.8% 192,025 201,600

201,171

9,146 104.8% ᇞ 428

Operating income(∆:loss)

3,301 3,430

3,579

277

275 100.9%

Net sales

2,667 3,100

3,202

535 120.1% 102 103.3% 29,729 29,100

29,375

ᇞ 353 98.8%

2 100.2% Net income attributable to owners of the parent(∆:loss)

108.4% 149 104.4%

Ordinary income(∆:loss)

親会社株主 帰属す 当期純利益 △:損失 1,334 1,350

1,352

18 101.4%

対 予想 FY2017 / Apr. 1, 2016 - Mar. 31, 2017 Change from FY2016 Change from forecast anounced Jan. 2017 親会社株主 帰属す 当期純利益 △:損失

対前期 対 予想

FY2017 / Apr. 1, 2016 - Mar. 31, 2017 Change from FY2016 Change from forecast anounced Jan. 2017

親会社株主 帰属す 当期純利益 △:損失

対前期

Net income attributable to owners of the parent(∆:loss)

346 103.6%

Ordinary income(∆:loss)

5,474 6,800

6,927

1,453 126.5% 127

(16)

期 業績予想 :Financial forecast for the year ending March 31, 2018

宝ホ

連結

:Takara Holdings Inc. ‐Consolidated‐

百万

:Millions of Yen

成 期 成 期 成 期 成 期

通期

通期

第 四半期累計第 四半期累計

実績

予想

増減

実績

予想

増減

FY2017 FY2018 Change % FY2017(1Q-2Q)FY2018(1Q-2Q) Change % Actual (a) Forecast (b) (b-a) (b/a) Actual (c) Forecast (d) (d-c) (d/c)

宝酒造

宝酒造 ン

そ 他

調整額

原価

総利益

費 保管料

広告宣伝費

研究開発費

管理費 そ 他

販売費及び一般管理費

宝酒造

宝酒造 ン

そ 他

調整額

営業利益 △:損失

利息 郤当金

そ 他営業外収益

Other, net

営業外収益

支払利息

そ 他営業外費用

Other, net

営業外費用

経常利益 △:損失

利益

損失

法人税

民税及び事業税

法人税等調整額

設備投資額

形 無形

減価償却費

形 無形

償却額

対前期

対前期

Change from FY2017 Change from FY2017(1Q-2Q)

149,452

153,000

3,547

102.4%

70,429

71,000

570

100.8%

Takara Shuzo Group

37,540

63,000

25,459

167.8%

15,137

31,000

15,862

Takara Bio Group

21,193

20,200

993

9,905

204.8%

Takara Shuzo International Group

29,375

33,200

3,824

113.0%

13,199

14,049

849

106.4%

10,049

143

Adjustment

39,017

39,000

17

100.0%

18,648

234,193

268,000

33,806

114.4%

107,509

125,000

17,490

116.3%

Net sales

120.2%

Cost of sales

94,010

105,000

10,989

111.7%

43,435

48,000

4,564

110.5%

140,182

163,000

22,817

116.3%

64,073

77,000

12,926

Gross profit

107.7%

Transportation and storage

3,198

3,300

101

103.2%

1,505

1,600

94

106.3%

Advertising

8,743

9,600

856

109.8%

4,269

4,600

330

販売

進費 販売

進引当金繰入

34,292

35,400

1,107

103.2%

16,382

16,800

417

102.5%

Sales promotion and allowance for s.p.

5,071

114.6%

Research and development

29,673

37,400

7,726

126.0%

13,977

17,900

3,922

128.1%

4,550

5,300

749

116.5%

2,093

2,400

306

Other, net

3,700

517

116.2%

1,393

1,800

406

Takara Bio Group

113.3%

SG&A expenses

5,071

5,600

528

110.4%

1,451

1,500

48

103.3%

Takara Shuzo Group

80,458

91,000

10,541

113.1%

38,228

43,300

Adjustment

13,551

14,000

448

103.3%

5,207

4,700

507

90.3%

Operating income(∆:loss)

72

900

827

8

87

95

659

600

59

91.0%

364

300

64

82.3%

Interest and Dividends income

878

600

278

68.3%

366

200

166

54.6%

231

68.4%

Non-operating income

481

600

118

124.5%

213

300

86

1,537

1,200

337

78.0%

731

500

140.4%

Interest and discounts expenses

262

200

62

76.1%

110

200

89

180.5%

175

154.1%

Non-operating expenses

14,344

14,400

55

100.4%

5,614

4,700

914

744

800

55

107.4%

324

500

Extraordinary gain

950

600

350

63.1%

60

83.7%

Ordinary income(∆:loss)

1,126

1,400

273

124.3%

21

21

100

39

166.3%

Extraordinary loss

税金等調整前当期純利益 △:損失

14,520

15,200

679

104.7%

5,575

4,600

975

82.5%

Income(∆:loss) before income taxes

5,208

5,500

216

104.1%

2,321

2,000

82

96.0%

Current income taxes

74

239

Deferred income taxes

当期純利益 △:損失

9,236

9,700

463

105.0%

3,492

2,600

892

74.4%

Net income(∆:loss)

非支郤株主 帰属す 当期純利益 △:損失

755

1,200

444

158.8%

315

200

115

63.4%

Net income attributable to the noncontrolling interest(∆:loss)

75.5%

Net income attributable to owners of the parent

6,658

7,051

392

105.9%

1,909

親会社株主 帰属す 当期純利益 △:損失

8,480

8,500

19

100.2%

3,177

2,400

777

Capital expenditures

3,100

607

124.4%

Depreciation and Amortization

5,171

6,600

1,428

127.6%

2,492

19,000

351

101.9%

Other

2,167

2,300

132

106.1%

976

1,000

23

102.4%

Other

129.2%

Takara Shuzo International Group

3,202

3,300

97

103.0%

1,377

487

889

35.4%

参照

関連したドキュメント

ⅴ)行使することにより又は当社に取得されることにより、普通株式1株当たりの新株予約権の払

原子力損害賠償紛争審査会が決定する「東京電力株式会社福島第一、第二原子力発電所事故による原子力損害

ⅴ)行使することにより又は当社に取得されることにより、普通株式1株当たりの新株予約権の払

ⅴ)行使することにより又は当社に取得されることにより、普通株式1株当たりの新株予約権の払

2019年6月4日にX-2ペネ内扉に,AWJ ※1 にて孔(孔径約0.21m)を開ける作業中,PCV内 のダスト濃度上昇を早期検知するためのダストモニタ(下記図の作業監視用DM①)の値が作 業管理値(1.7×10

©Tokyo Electric Power Company Holdings, Inc.. All

(2号機) 段階的な 取り出し

ⅴ)行使することにより又は当社に取得されることにより、普通株式1株当たりの新株予約権の払